Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (hiv) epidemic in new york city

1989 ◽  
Vol 29 (3) ◽  
pp. 181-185 ◽  
Author(s):  
David M. Novick ◽  
Harold L. Trigg ◽  
Don C. Des Jarlais ◽  
Samuel R. Friedman ◽  
David Vlahov ◽  
...  
Keyword(s):  
New York ◽  
Human Immunodeficiency Virus ◽  
New York City ◽  
York City ◽  
Drug Users ◽  
Early Years ◽  
Hiv Epidemic ◽  
Immunodeficiency Virus ◽  
Parenteral Drug

scholarly journals Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City

2020 ◽  
Vol 71 (11) ◽  
pp. 2933-2938 ◽  
Author(s):  
Keith Sigel ◽  
Talia Swartz ◽  
Eddye Golden ◽  
Ishan Paranjpe ◽  
Sulaiman Somani ◽  
...  
Keyword(s):  
New York ◽  
Human Immunodeficiency Virus ◽  
Mechanical Ventilation ◽  
New York City ◽  
York City ◽  
Cumulative Incidence ◽  
Clinical Characteristics ◽  
Hiv Status ◽  
Immunodeficiency Virus ◽  
Race Ethnicity

Abstract Background There are limited data regarding the clinical impact of coronavirus disease 2019 (COVID-19) on people living with human immunodeficiency virus (PLWH). In this study, we compared outcomes for PLWH with COVID-19 to a matched comparison group. Methods We identified 88 PLWH hospitalized with laboratory-confirmed COVID-19 in our hospital system in New York City between 12 March and 23 April 2020. We collected data on baseline clinical characteristics, laboratory values, HIV status, treatment, and outcomes from this group and matched comparators (1 PLWH to up to 5 patients by age, sex, race/ethnicity, and calendar week of infection). We compared clinical characteristics and outcomes (death, mechanical ventilation, hospital discharge) for these groups, as well as cumulative incidence of death by HIV status. Results Patients did not differ significantly by HIV status by age, sex, or race/ethnicity due to the matching algorithm. PLWH hospitalized with COVID-19 had high proportions of HIV virologic control on antiretroviral therapy. PLWH had greater proportions of smoking (P < .001) and comorbid illness than uninfected comparators. There was no difference in COVID-19 severity on admission by HIV status (P = .15). Poor outcomes for hospitalized PLWH were frequent but similar to proportions in comparators; 18% required mechanical ventilation and 21% died during follow-up (compared with 23% and 20%, respectively). There was similar cumulative incidence of death over time by HIV status (P = .94). Conclusions We found no differences in adverse outcomes associated with HIV infection for hospitalized COVID-19 patients compared with a demographically similar patient group.

scholarly journals What happened to the HIV epidemic among non-injecting drug users in New York City?

Addiction ◽  
2016 ◽  
Vol 112 (2) ◽  
pp. 290-298 ◽  
Author(s):  
Don C. Des Jarlais ◽  
Kamyar Arasteh ◽  
Courtney McKnight ◽  
Jonathan Feelemyer ◽  
Aimee N. C. Campbell ◽  
...  
Keyword(s):  
New York ◽  
New York City ◽  
York City ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Hiv Epidemic

Lymphogranuloma Venereum in Human Immunodeficiency Virus???Infected Individuals in New York City

2006 ◽  
Vol 40 (5) ◽  
pp. 385-390 ◽  
Author(s):  
Allen Ahdoot ◽  
Donald P. Kotler ◽  
Jin S. Suh ◽  
Charles Kutler ◽  
Rachel Flamholz
Keyword(s):  
New York ◽  
Human Immunodeficiency Virus ◽  
New York City ◽  
York City ◽  
Lymphogranuloma Venereum ◽  
Immunodeficiency Virus

Aging cohort of perinatally human immunodeficiency virus-infected children in New York City

2001 ◽  
pp. 511-517 ◽  
Author(s):  
ELAINE J. ABRAMS ◽  
JEREMY WEEDON ◽  
JEANNE BERTOLLI ◽  
KATIE BORNSCHLEGEL ◽  
JOSEPH CERVIA ◽  
...  
Keyword(s):  
New York ◽  
Human Immunodeficiency Virus ◽  
New York City ◽  
York City ◽  
Immunodeficiency Virus
Sign in / Sign up

Export Citation Format

Share Document